4 February in the Indian stock market

What our records show for 4 February: the Nifty 50's close in each year we hold, companies that first listed on this date, bonus issues and splits that went ex, and symbol changes.

  • Nifty 50 by year
  • Listings
  • Bonuses and splits
  • Symbol changes
Nifty 50 closes
4
years with a close on 4 February
Listings
4
companies first traded on this date
Bonuses and splits
3
went ex on this date
Symbol changes
0
took effect on this date

Nifty 50 on 4 February, by year

YearCloseChange on the day
202625,776.00
+0.19%
202523,739.25
+1.62%
202217,516.30
−0.25%
202114,895.65
+0.71%

Price index, as published by NSE. Weekends and market holidays have no close, so some years are missing.

Listed on this date

  • 2025AGARWALEYE Dr. Agarwal's Health Care Limited
  • 2019XELPMOC Xelpmoc Design And Tech Limited
  • 2015LAMBODHARA Lambodhara Textiles Limited
  • 2003TNTELE Tamilnadu Telecommunication Limited

Companies listed on NSE today whose first trading day was this date. The latest 12.

Bonuses and splits, ex-date

Of companies listed today. The latest 12.

Questions

How did the Nifty 50 move on 4 February in past years?
The Nifty 50 closed at these levels on 4 February in the years our records hold, with the change on the day in brackets. 2021: 14,895.65 (+0.71%); 2022: 17,516.30 (−0.25%); 2025: 23,739.25 (+1.62%); 2026: 25,776.00 (+0.19%). Weekends and holidays have no close.
Which companies listed on NSE on 4 February?
Companies that are listed today and first traded on 4 February include Tamilnadu Telecommunication Limited (2003), Lambodhara Textiles Limited (2015), Xelpmoc Design And Tech Limited (2019), Dr. Agarwal's Health Care Limited (2025).
Which bonus issues and splits had an ex-date on 4 February?
SANWARIA in 2008: Split, face value ₹2 to ₹1; CONCOR in 2019: Bonus 1:4; REDTAPE in 2025: Bonus 3:1.

Pick another day

Educational data from NSE, not investment advice, research or a recommendation to buy, sell or hold any security. Past performance does not indicate future results. Read the Disclaimer.